Losing weight can often seem like a daunting task but the key to success often lies in making small and sustainable changes to your lifestyle. A recent weight loss transformation story has caught ...

Ritters Hardware in Mechanicsburg closed earlier this month after 117 years in business. The shop, a landmark on West Main Street, closed on Oct. 3. However, there’s still more inventory to sell, ...

Fauzi: Prabhas stars as a soldier in a 1940s British-India action-drama, featuring veterans Mithun Chakraborty, Anupam Kher, and Jaya Prada. On Prabhas' 46th birth anniversary, the makers of his ...

Researchers have for the first time created a reconfigurable polariton 2D quasicrystal. The team from the Skolkovo Institute of Science and Technology (Skoltech), in collaboration with colleagues from ...

Our online Pre-Business program is currently open to transfer students only. On average, students complete the Pre-Business program in less than two years. Our Pre-Business program is designed with ...

The festive season comes with a long to-do list: card parties, family get-togethers, dinners, brunches, gifting…. It's all fun and excitement till one faces the inevitable sartorial problem: What to ...

An amateur footballer got an unexpectedly early bath after he was given his marching orders by two cops during his pre-match warm-up. Sean Ferris (25), who plays as a striker for Celtic Bhoys ...

The case involved Priya Blue Industries Pvt. Ltd., whose original assessment for A.Y. 2016-17 was completed under scrutiny (Section 143(3)). A subsequent search operation under Section 132 was ...

Billionaire investor Radhakishan Damani, founder of Avenue Supermarts (DMart), and SBI Mutual Fund are each likely to invest around Rs 100 crore in eyewear retailer Lenskart ahead of its initial ...

They are so close that Taylor Swift once dubbed Ed Sheeran her 'second brother'. But the Daily Mail understands that their relationship has been 'strained' of late after the American singer released ...

Viking Therapeutics VKTX is set to report third-quarter 2025 earnings on Oct. 22, after market close. Since the company lacks a marketed drug in its portfolio, no revenues are expected to be recorded.